Clinical predictors for survival with the addition of chemotherapy in patients with recurrent-metastatic squamous cell carcinoma of the head and neck after progression on immune checkpoint inhibitors

被引：1
|
作者：
Issa, M. [1 ]
Klamer, B. [2 ]
Bhateja, P. [3 ]
Karivedu, V. [3 ]
Laliotis, G. [4 ]
Dibs, K. [5 ]
Mladkova, N. [5 ]
Pan, X.
Old, M. [5 ]
Gamez, M. [5 ]
Grecula, J. [5 ]
Jhawar, S. [5 ]
Mitchell, D. [5 ]
Baliga, S. [5 ]
Carrau, R. [6 ]
Rocco, J. [6 ]
Bonomi, M. [3 ]
Blakaj, D.
机构：
[1] Ohio State Univ, Med Oncol, James Canc Hosp, Columbus, OH USA
[2] Ohio State Univ, Sch Biomed Sci, Ctr Biostat, OSUCCC,Comprehens Canc Ctr, Columbus, OH USA
[3] Ohio State Univ, Dept Med Oncol, OSUCCC, Comprehens Canc Ctr, Columbus, OH USA
[4] Sidney Kimmel Comprehensive Canc Ctr, Med Oncol, Baltimore, MD USA
[5] Ohio State Univ, Radiat Oncol, Comprehens Canc Ctr, OSUCCC, Columbus, OH USA
[6] Ohio State Univ, Otolaryngol, James Canc Hosp, Columbus, OH USA
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.08.1298
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
888P
引用
收藏
页码：S797 / S798
页数：2
相关论文
共 50 条
  • [41] Association of LIPI score with immune checkpoint inhibitors (ICI) outcomes in recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) patients (pts)
    Gomez, R. G. Herrera
    Mezquita, L.
    Auclin, E.
    Saleh, K.
    Rotllan, N. Baste
    Iacobs, M.
    Bursuc, S. C.
    Badis, L. Mayache
    Ferrand, F. R.
    Casiraghi, O.
    Temam, S.
    Breuskin, I.
    Tao, Y.
    Besse, B.
    Even, C.
    ANNALS OF ONCOLOGY, 2018, 29
  • [42] Development of a predictive radiomics signature for response to immune checkpoint inhibitors (ICIs) in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (RM-SCCHN)
    Prawira, A.
    Dufort, P.
    Halankar, J.
    Paravasthu, D. M.
    Hansen, A.
    Spreafico, A.
    Razak, A. R. Abdul
    Chen, E.
    Jang, R. W.
    Metser, U.
    Siu, L. L.
    ANNALS OF ONCOLOGY, 2016, 27
  • [43] Comparative safety of immune checkpoint inhibitors in recurrent or metastatic head and neck squamous cell carcinoma: a systematic review and network meta-analysis
    Wang, Shan
    Yan, Li
    Yu, Jing
    Lu, Cheng
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2024, 281 (07) : 3385 - 3395
  • [44] Comparative safety of immune checkpoint inhibitors in recurrent or metastatic head and neck squamous cell carcinoma: a systematic review and network meta-analysis
    Wang, Shan
    Yan, Li
    Yu, Jing
    Lu, Cheng
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2024, 281 (7) : 3385 - 3395
  • [45] Hypothyroidism in Head and Neck Squamous Cell Carcinoma Patients Receiving Radiotherapy With or Without Immune Checkpoint Inhibitors
    Leddon, Jennifer L.
    Chirra, Martina
    Frankart, Andrew J.
    Agrawal, Arushi
    Roof, Logan
    Trotier, Danny
    Shaikh, Hira
    Stone, Timothy
    Jandarov, Roman
    Takiar, Vinita
    Wise-Draper, Trisha M.
    LARYNGOSCOPE, 2021, 131 (07): : E2413 - E2419
  • [46] Current and Future Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma
    Park, Jong Chul
    Krishnakumar, Hari N.
    Saladi, Srinivas Vinod
    CURRENT ONCOLOGY, 2022, 29 (06) : 4185 - 4198
  • [47] Clinical Variables Associated with Survival and Treatment Response in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
    Haring, C. T.
    Kana, L.
    Dermody, S.
    Smith, J. D.
    Brenner, J. C.
    Casper, K.
    Chinn, S. B.
    Malloy, K.
    Mierzwa, M. L.
    Prince, M. E.
    Rosko, A. J.
    Schonewolf, C.
    Shah, J. L.
    Stucken, C. L.
    Shuman, A.
    Spector, M.
    Worden, F.
    Swiecicki, P. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 112 (05): : E44 - E44
  • [48] The head and neck lung immune prognostic index (HN-LIPI): A prognostic score for immune checkpoint inhibitors (ICI) in recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) patients
    Gomez, R. G. Herrera
    Mezquita, L.
    Auclin, E.
    Heraudet, L.
    Plana, M.
    Salas, S.
    Cristina, V.
    Garcia Castano, A.
    Arrazubi, V.
    Grau, J. J.
    Saleh, K.
    Cirauqui Cirauqui, B.
    Nin, R. Mesia
    Even, C.
    Taberna, M.
    Daste, A.
    Peters, S.
    Besse, B.
    Baste-Rotllan, N.
    ANNALS OF ONCOLOGY, 2019, 30
  • [49] Impact of salvage chemotherapy after immune checkpoint inhibitor for recurrent or metastatic head and neck cancer
    Matoba, Takuma
    Minohara, Kiyoshi
    Kawakita, Daisuke
    Sawabe, Michi
    Takano, Gaku
    Oguri, Keisuke
    Murashima, Akihiro
    Iwaki, Sho
    Tsuge, Hiroshi
    Imaizumi, Sae
    Hojo, Wataru
    Kondo, Ayano
    Tsukamoto, Koji
    Iwasaki, Shinichi
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2024, 46 (08): : 1855 - 1864
  • [50] S-1 MONOTHERAPY FOR RECURRENT OR METASTATIC SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK AFTER PROGRESSION ON PLATINUM-BASED CHEMOTHERAPY
    Yokota, T.
    Onozawa, Y.
    Boku, N.
    Hamauchi, S.
    Tsushima, T.
    Taniguchi, H.
    Todaka, A.
    Machida, N.
    Yamazaki, K.
    Fukutomi, A.
    Yasui, H.
    ANNALS OF ONCOLOGY, 2012, 23 : 125 - 125
12345